Search - tctmd.com

Displaying 241 - 260 of 359

Sort: Relevancy | Date

News Daily News

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Shelley Wood

February 19, 2019

Manuscript

The Evolution of the Program Coordinator: From One Valve to the Whole Heart

January 07, 2019

News Daily News

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

Todd Neale

November 20, 2018

News Conference News TCT 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

L.A. McKeown

September 27, 2018

News Conference News TCT 2018

NEOPRO: Two Next-Gen TAVR Valves Show Promise at 30 Days

Yael L. Maxwell

September 25, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

Shelley Wood

September 23, 2018

News Conference News TCT 2018

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

Yael L. Maxwell

September 23, 2018

Presentation TCT 2018

Evolution of Caval Valves (CAVI) Last Resort TR Patients Technology and Clinical Updates

Presenter: Alexander Lauten

September 23, 2018

News Daily News

TAVR Superior to Surgery at Getting High-Risk Patients Home Sooner

Michael O'Riordan

September 20, 2018

News Industry News

Medtronic Announces Clinical Study of Transcatheter Aortic Valve Replacement in Aortic Stenosis Patients with Bicuspid Valves

September 18, 2018

News Conference News ESC 2018

TAVR Debris Captured by Sentinel Embolic Protection Differs by Valve Type

Yael L. Maxwell

September 06, 2018

News Daily News

No Harm Done: Foregoing Routine TEE and General Anesthesia in TAVR

Caitlin E. Cox

July 17, 2018

News Conference News The Structural Heart Disease Summit 2018

Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli

Michael O'Riordan

June 26, 2018

Presentation The Structural Heart Disease Summit 2018

The Vancouver Minimalist Clinical Care Pathway: Updates from the 3M Trial and Evolution to BENCHMARK

Presenter: Vinod H. Thourani, John G. Webb, David A. Wood

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Program Update: The Evolut R/PRO TAVR System: Design Characteristics, Clinical Data, and Future Vision

Presenter: Axel Linke, Vinod H. Thourani, Jeffrey J. Popma

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Evolution of Caval Valves (CAVI)Last Resort TR Patients: Technology and Clinical Updates

Presenter: Alexander Lauten

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Early Degeneration of First Generation Sapien Valve Treated With Valve-in-Valve Evolut R Valve

Presenter: Howard C. Herrmann, Fabian Nietlispach, Cenap Undemir, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Evolut R Low-Risk

Presenter: Jeffrey J. Popma

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Updates from the EVOLUT R Aortic Valve-in-Valve Registry (VIVA)

Presenter: Vinayak Bapat, Ran Kornowski

June 21, 2018

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

Advertisement

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

The Evolution of the Program Coordinator: From One Valve to the Whole Heart

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

NEOPRO: Two Next-Gen TAVR Valves Show Promise at 30 Days

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

Evolution of Caval Valves (CAVI) Last Resort TR Patients Technology and Clinical Updates

TAVR Superior to Surgery at Getting High-Risk Patients Home Sooner

Medtronic Announces Clinical Study of Transcatheter Aortic Valve Replacement in Aortic Stenosis Patients with Bicuspid Valves

TAVR Debris Captured by Sentinel Embolic Protection Differs by Valve Type

No Harm Done: Foregoing Routine TEE and General Anesthesia in TAVR

Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli

The Vancouver Minimalist Clinical Care Pathway: Updates from the 3M Trial and Evolution to BENCHMARK

Program Update: The Evolut R/PRO TAVR System: Design Characteristics, Clinical Data, and Future Vision

Evolution of Caval Valves (CAVI)Last Resort TR Patients: Technology and Clinical Updates

Early Degeneration of First Generation Sapien Valve Treated With Valve-in-Valve Evolut R Valve

Evolut R Low-Risk

Updates from the EVOLUT R Aortic Valve-in-Valve Registry (VIVA)

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content